189 results on '"J. Branchereau"'
Search Results
152. Remission of type 1 diabetes mellitus recurrence 6 years after simultaneous pancreas and kidney transplantation.
- Author
-
Kervella D, Scharbarg E, Mahot-Moreau P, Renaudin K, Branchereau J, Karam G, Chaillous L, Bach K, and Cantarovich D
- Subjects
- Adult, Female, Graft Survival immunology, Humans, Prognosis, Recurrence, Remission Induction, Diabetes Mellitus, Type 1 surgery, Graft Survival drug effects, Immunosuppressive Agents therapeutic use, Kidney Transplantation methods, Pancreas Transplantation methods
- Published
- 2018
- Full Text
- View/download PDF
153. Transplant nephrectomy after graft failure: is it so risky? Impact on morbidity, mortality and alloimmunization.
- Author
-
Chowaniec Y, Luyckx F, Karam G, Glemain P, Dantal J, Rigaud J, and Branchereau J
- Subjects
- Adolescent, Adult, Aged, Blood Transfusion, Child, Female, Humans, Kidney Transplantation, Length of Stay, Male, Middle Aged, Nephrectomy mortality, Risk Factors, Sepsis surgery, Thrombosis surgery, Young Adult, Blood Loss, Surgical, Graft Rejection surgery, HLA Antigens immunology, Kidney Neoplasms surgery, Nephrectomy adverse effects, Postoperative Complications etiology
- Abstract
Purpose: To determine the impact of transplant nephrectomy on morbidity and mortality and HLA immunization., Methods: All patients who underwent transplant nephrectomy in our centre between 2000 and 2016 were included in this study. A total of 2822 renal transplantations and 180 transplant nephrectomies were performed during this period., Results: The indications for transplant nephrectomy were graft intolerance syndrome: 47.2%, sepsis: 22.2%, vascular thrombosis: 15.5%, tumour: 8.3% and other 6.8%. Transplant nephrectomies were performed via an intracapsular approach in 61.7% of cases. The blood transfusion rate was 50%, the morbidity rate was 38% and the mortality rate was 3%. Transplant nephrectomies more than 12 months after renal transplant failure were associated with more complications (p = 0.006). Transfusions in the context of transplant nephrectomy had no significant impact on alloimmunization., Conclusion: The risk of bleeding, and therefore of transfusion, constitutes the major challenge of this surgery in patients eligible for retransplantation. Even if transfusions in this context of transplant nephrectomy had no significant impact on alloimmunization, this high-risk surgery, whenever possible, must be performed electively in a well-prepared patient.
- Published
- 2018
- Full Text
- View/download PDF
154. Influence of inguinal hernia repair on male fertility.
- Author
-
Bouchot O, Branchereau J, and Perrouin-Verbe MA
- Subjects
- Herniorrhaphy adverse effects, Herniorrhaphy instrumentation, Humans, Infertility, Male etiology, Male, Postoperative Complications etiology, Surgical Mesh adverse effects, Fertility Preservation methods, Hernia, Inguinal surgery, Herniorrhaphy methods, Infertility, Male prevention & control, Postoperative Complications prevention & control
- Abstract
Male infertility is a rare but certainly underestimated iatrogenic complication of inguinal hernia repair. The use of polypropylene mesh, recommended by the European Hernia Society, either via the traditional, open or laparoscopic approach, is responsible for surrounding inflammation followed by fibrosis, but there is no proven increase in vas deferens obstruction found in the literature. Prevention is essential to reduce the incidence of this complication including screening for patients at risk and mastery of surgical techniques., (Copyright © 2018. Published by Elsevier Masson SAS.)
- Published
- 2018
- Full Text
- View/download PDF
155. [Post operative fistula after photovaporisation (PVP) laser green light XPS 180W: About two cases].
- Author
-
Mazeaud C, Le Clerc QC, Robine E, Madec FX, Perrouin-Verbe MA, Nedelec M, Rigaud J, and Branchereau J
- Subjects
- Aged, Humans, Male, Prostatic Hyperplasia surgery, Fistula etiology, Laser Therapy adverse effects, Postoperative Complications etiology, Prostatic Diseases etiology
- Published
- 2018
- Full Text
- View/download PDF
156. [Long-term outcomes of prostate cancer patients with lymph nodes metastasis after radical prostatectomy and pelvic lymph node dissection].
- Author
-
De Vergie S, Gaschignard N, Baron M, Branchereau J, Luyckx F, Butel T, Perrouin-Verbe MA, Bouchot O, and Rigaud J
- Subjects
- Aged, Humans, Lymphatic Metastasis, Male, Middle Aged, Retrospective Studies, Time Factors, Treatment Outcome, Lymph Node Excision, Prostatectomy methods, Prostatic Neoplasms pathology, Prostatic Neoplasms surgery
- Abstract
Introduction: The aim of this study was to evaluate biochemical recurrence-free survival (RFS) and to identify useful predictors of such survival in localized prostate cancer patients (cN0) and pelvic lymph node metastasis (pN+) treated with radical prostatectomy and pelvic lymph node dissection., Patients and Methods: This multicenter and retrospective study, assessed overall survival (OS), cancer specific survival (CSS) and biochemical recurrence-free survival (RFS), between January 2005 until December 2010 with 5 years of distance. We evaluated factors predicting long-term RFS in node positive prostate cancer patients., Results: Thus, 30 patients were included. Median follow-up was 89.9±27.4 months. After surgery, patients were treated with surveillance (n=4, 13.5%), adjuvant hormone therapy (n=22, 73%) or combination of radio and hormone therapy, (n=4, 13.5%). During the follow-up, 50% of patients had biochemical recurrence, with a mean time period of 38±30 months. Five and 10-year RFS were 57% and 41% respectively. Extra lymph nodes extension (P=0.00021) and pathological margin status (P=0.0065) were independent predictors of 5-year RFS., Conclusion: Biochemical RFS of patients treated with radical prostatectomy and subclinical lymph node metastatic disease is adequate and multifactorial. However, this study identifies pathological margin status and extra lymph node extension as independent factors of b RFS., Level of Evidence: 4., (Copyright © 2017 Elsevier Masson SAS. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
157. Management of renal transplant urolithiasis: a multicentre study by the French Urology Association Transplantation Committee.
- Author
-
Branchereau J, Timsit MO, Neuzillet Y, Bessède T, Thuret R, Gigante M, Tillou X, Codas R, Boutin J, Doerfler A, Sallusto F, Culty T, Delaporte V, Brichart N, Barrou B, Salomon L, Karam G, Rigaud J, Badet L, and Kleinklauss F
- Subjects
- Female, Humans, Male, Middle Aged, Retrospective Studies, Kidney Transplantation adverse effects, Urolithiasis etiology, Urolithiasis therapy
- Abstract
Purpose: Urolithiasis is rare among renal transplant recipients and its management has not been clearly defined., Methods: This multicentre retrospective study was organised by the Comité de Transplantation de l'Association Française d'Urologie (French Urology Association transplantation committee). Statistical analysis was performed with SPSS 19 software., Results: Ninety-five patients were included in this study. Renal transplant urolithiasis was an incidental finding in 55% of cases, mostly on a routine follow-up ultrasound examination. One half of symptomatic stones were due to urinary tract infection and the other half were due to an episode of acute renal failure. The initial management following diagnosis of urolithiasis was double J stenting (27%), nephrostomy tube placement (21%), or watchful waiting (52%). Definitive management consisted of: watchful waiting (48%), extracorporeal lithotripsy (13%), rigid or flexible ureteroscopy (26%), percutaneous nephrolithotomy (11%) and surgical pyelotomy (2%). All transplants remained functional following treatment of the stone. The main limitation is the retrospective design., Conclusions: The incidence of lithiasis could be higher in kidney transplanted patients due to a possible anatomical or metabolical abnormalities. The therapeutic management of renal transplant urolithiasis appears to be comparable to that of native kidney urolithiasis.
- Published
- 2018
- Full Text
- View/download PDF
158. [Flexible ureterorenoscopy and laser lithotripsy for upper urinary tract stones in neurologic patients with severe motor disability].
- Author
-
Madec FX, Suply E, Luyckx F, Nedelec M, Chowaniec Y, Branchereau J, Le Normand L, and Glemain P
- Subjects
- Adult, Combined Modality Therapy, Female, Humans, Male, Retrospective Studies, Severity of Illness Index, Kidney Calculi etiology, Kidney Calculi therapy, Lithotripsy, Laser, Nervous System Diseases complications, Ureteral Calculi etiology, Ureteral Calculi therapy, Ureteroscopes, Ureteroscopy instrumentation
- Abstract
Objective: The study's objective was to evaluate the effectiveness and morbidity of flexible ureterorenoscopy and laser lithotripsy for upper urinary tract stones in patients with a nervous system pathology including severe motor disability., Methods: Between 2006 and 2013, we retrospectively analyzed 83 flexible ureterorenoscopy to treat 63 kidneys in 42 patients. Stone free (SF) kidneys defined as an absence of stones on computerized tomography, renal ultrasound, X-ray or direct ureterorenoscopy, were considered a surgical success. Complications were classified according to the Clavien-Dindo system., Results: Success rates were 49.2 %, 57.1 % and 58.7 %, respectively after first, second and third flexible ureterorenoscopy procedure. Clearance after one procedure was achieved in 64.3 % of cases involving less than 20mm stones. No major complication (Clavien-Dindo>2) was described (0 %). Complication rates were 44.7 %, with 31.6 % Clavien-Dindo 2. The main complication was urosepsis, which occurred in 27.6 % of cases., Conclusion: Flexible ureteroscopy and laser lithotripsies for upper urinary tract stones in neurologic patients with severe motor disability are associated with a lower success rate and some frequent low grade complications compared to overall population. In clinical practice, the indications of flexible ureterorenoscopy for these patients seem restricted., Level of Evidence: 5., (Copyright © 2017 Elsevier Masson SAS. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
159. [Analysis of success rates of uretroplasty for adult male bulbar urethral stricture: A systematic review].
- Author
-
Robine E, Rigaud J, Luyckx F, Le Clerc QC, Madec FX, Bouchot O, and Branchereau J
- Subjects
- Adult, Humans, Male, Remission Induction, Urologic Surgical Procedures, Male methods, Urethra surgery, Urethral Stricture surgery
- Abstract
Male urethral stricture disease is prevalent and has an important impact on quality of life. Direct visual urethrotomy and dilatations have high rates of recurrence., Objectives: The aim of this review of literature was to evaluate the success rates of different techniques of urethroplasty for strictures of the bulbar urethra., Methods: We performed a systematic review of the MEDLINE literature from 2004 to 2015 following the PRISMA's statement recommendations. Key words were: urethroplasty, urethral reconstruction, onlay, graft, urethral stricture. Inclusion criteria were original articles describing the results of urethroplasty for bulbar urethral stricture in an adult male population. A minimum follow-up of 24 months was required., Results: From 891 articles of the literature, 20 are studied in this review. Only 3 studies were prospective. The success rate of anastomotic urethroplasty varied from 68.7 to 98.8% for strictures from 1 to 3.5cm, from 60 to 96.9% for augmented urethroplasty performed for strictures from 4.2 to 4.7cm. Substitution urethroplasty with grafts presented from 75 to 89.8% of success for strictures from 2.6 and 4.36cm. Overall, 19/20 studies used buccal mucosal graft., Conclusion: The success rate of urethroplasty for bulbar urethral stricture is high; the surgical technique should be adapted to the length of the stricture., (Copyright © 2016 Elsevier Masson SAS. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
160. Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection.
- Author
-
Ville S, Poirier N, Branchereau J, Charpy V, Pengam S, Nerriere-Daguin V, Le Bas-Bernardet S, Coulon F, Mary C, Chenouard A, Hervouet J, Minault D, Nedellec S, Renaudin K, Vanhove B, and Blancho G
- Subjects
- Animals, Mice, Papio, Abatacept pharmacology, Antibodies drug effects, Antibodies immunology, CD28 Antigens immunology, Graft Rejection immunology, Immunosuppressive Agents pharmacology
- Abstract
Belatacept is a biologic that targets CD80/86 and prevents its interaction with CD28 and its alternative ligand, cytotoxic T lymphocyte antigen 4 (CTLA-4). Clinical experience in kidney transplantation has revealed a high incidence of rejection with belatacept, especially with intensive regimens, suggesting that blocking CTLA-4 is deleterious. We performed a head to head assessment of FR104 (n=5), a selective pegylated Fab' antibody fragment antagonist of CD28 that does not block the CTLA-4 pathway, and belatacept (n=5) in kidney allotransplantation in baboons. The biologics were supplemented with an initial 1-month treatment with low-dose tacrolimus. In cases of acute rejection, animals also received steroids. In the belatacept group, four of five recipients developed severe, steroid-resistant acute cellular rejection, whereas FR104-treated animals did not. Assessment of regulatory T cell-specific demethylated region methylation status in 1-month biopsy samples revealed a nonsignificant trend for higher regulatory T cell frequencies in FR104-treated animals. Transcriptional analysis did not reveal significant differences in Th17 cytokines but did reveal higher levels of IL-21, the main cytokine secreted by CD4 T follicular helper (Tfh) cells, in belatacept-treated animals. In vitro, FR104 controlled the proliferative response of human preexisting Tfh cells more efficiently than belatacept. In mice, selective CD28 blockade also controlled Tfh memory cell responses to KLH stimulation more efficiently than CD80/86 blockade. Our data reveal that selective CD28 blockade and belatacept exert different effects on mechanisms of renal allograft rejection, particularly at the level of Tfh cell stimulation., (Copyright © 2016 by the American Society of Nephrology.)
- Published
- 2016
- Full Text
- View/download PDF
161. [Urinary lithiasis in renal transplant recipient].
- Author
-
Branchereau J, Thuret R, Kleinclauss F, and Timsit MO
- Subjects
- Humans, Postoperative Complications diagnosis, Postoperative Complications therapy, Kidney Transplantation, Urolithiasis diagnosis, Urolithiasis therapy
- Abstract
Objectives: To report epidemiology and characteristics of urinary lithiasis and its management in kidney allograft at the time of organ procurement or after kidney transplantation., Material and Methods: An exhaustive systematic review of the scientific literature was performed in the Medline database (http://www.ncbi.nlm.nih.gov) and Embase (http://www.embase.com) using different associations of the following keywords (MESH): urinary lithiasis, stone, kidney transplantation. Publications obtained were selected based on methodology, language, date of publication (last 10 years) and relevance. Prospective and retrospective studies, in English or French, review articles; meta-analysis and guidelines were selected and analyzed. This search found 58 articles. After reading, 37 were included in the text based on their relevance., Results: Frequency of urinary lithiasis in renal transplant recipient is similar to those observed in the general population. Generally, urinary lithiasis of the graft is asymptomatic because of renal denervation after organ procurement and transplantation. Nevertheless, this situation may be at high risk due to the immunosuppressed state of the recipient with a unique functioning kidney. Most of the time, the diagnosis is incidental during routine post-transplantation follow-up. Management of urolithiasis in renal transplant recipient is similar to that performed in general population., Conclusion: Due to its potential severity in transplanted immunosuppressed patients with a sole kidney, urolithiasis requires expert urological management., (Copyright © 2016 Elsevier Masson SAS. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
162. [Renal transplantation in 2046: Future and perspectives].
- Author
-
Timsit MO, Branchereau J, Thuret R, and Kleinclauss F
- Subjects
- Forecasting, Humans, Immunomodulation, Tissue Engineering, Transplantation, Heterologous, Kidney Failure, Chronic surgery, Kidney Transplantation trends
- Abstract
Objectives: To report major findings that may build the future of kidney transplantation., Material and Methods: Relevant publications were identified through Medline (http://www.ncbi.nlm.nih.gov) and Embase (http://www.embase.com) database from 1960 to 2016 using the following keywords, in association, "bio-engineering; heterotransplantation; immunomodulation; kidney; regenerative medicine; xenotransplantation". Articles were selected according to methods, language of publication and relevance. A total of 5621 articles were identified including 2264 for xenotransplantation, 1058 for regenerative medicine and 2299 for immunomodulation; after careful selection, 86 publications were eligible for our review., Results: Despite genetic constructs, xenotransplantation faces the inevitable obstacle of species barrier. Uncertainty regarding xenograft acceptance by recipients as well as ethical considerations due to the debatable utilization of animal lives, are major limits for its future. Regenerative medicine and tridimensional bioprinting allow successful implantation of organs. Bioengineering, using decellularized tissue matrices or synthetic scaffold, seeded with pluripotent cells and assembled using bioreactors, provide exciting results but remain far for reconstituting renal complexity and vascular patency. Immune tolerance may be achieved through a tough initial T-cell depletion or a combined haplo-identical bone marrow transplant leading to lymphohematopoietic chimerism., Conclusion: Current researches aim to increase the pool of organs available for transplantation (xenotransplants and bio-artificial kidneys) and to increase allograft survival through the induction of immune tolerance. Reported results suggest the onset of a thrilling new era for renal transplantation providing end-stage renal disease-patients with an improved survival and quality of life., (Copyright © 2016 Elsevier Masson SAS. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
163. [Simultaneous pancreas and kidney transplantation].
- Author
-
Badet L, Matillon X, Codas R, Branchereau J, Karam G, Timsit MO, Thuret R, and Kleinclauss F
- Subjects
- Humans, Preoperative Care methods, Treatment Outcome, Kidney Transplantation methods, Pancreas Transplantation methods
- Abstract
Objectives: To perform a State of The Art about the different aspects of pancreas transplantation such as indications, technical features, immunosuppressive strategies and outcomes of simultaneous pancreas-kidney transplantation., Material and Methods: An exhaustive systematic review of the scientific literature was performed in the Medline database (http://www.ncbi.nlm.nih.gov) and Embase (http://www.embase.com) using different associations of the following keywords (MESH) : « pancreas transplantation; kidney transplantation; simultaneous pancreas-kidney transplantation; immunosuppression ». Publications obtained were selected based on methodology, language, date of publication (last 20 years) and relevance. Prospective and retrospective studies, in English or French, review articles; meta-analysis and guidelines were selected and analyzed. This search found 2736 articles. After reading titles and abstracts, 23 were included in the text, based on their relevance., Results: These last few years, considerable progresses were done in optimizing indication for pancreas transplantation, as well as surgical improvement and a better used of immunosuppression. In the first part of this article, demographics, indication and pre-transplant evaluation will be described. The different techniques of procurement, preparation and transplantation will then be discussed. Finally, the results and outcomes of pancreas transplantation will be reported., Conclusions: Despite its morbidity, pancreas transplantation is the optimal treatment of end stage renal disease in diabetic patients under 55. Long-term results and quality of life improvement after pancreas transplantation are excellent., Level of Evidence: NA., (Copyright © 2016 Elsevier Masson SAS. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
164. What do we know about treatment sequencing of abiraterone, enzalutamide, and chemotherapy in metastatic castration-resistant prostate cancer?
- Author
-
Lebdai S, Basset V, Branchereau J, de La Taille A, Flamand V, Lebret T, Murez T, Neuzillet Y, Ploussard G, and Audenet F
- Subjects
- Benzamides, Docetaxel, Drug Resistance, Neoplasm, Drug Therapy, Combination, Humans, Male, Neoplasm Metastasis, Nitriles, Phenylthiohydantoin administration & dosage, Prostatic Neoplasms, Castration-Resistant pathology, Androstenes administration & dosage, Antineoplastic Combined Chemotherapy Protocols administration & dosage, Phenylthiohydantoin analogs & derivatives, Prostatic Neoplasms, Castration-Resistant drug therapy, Taxoids administration & dosage
- Abstract
Purpose: To present a systematic review of the different therapeutic sequences in metastatic castration-resistant prostate cancer (mCRPC)., Methods: Evidence acquisition on therapeutic sequences in mCRPC was performed by a MEDLINE search using combination of the following key words: "prostate cancer," "metastatic," "castration resistant," "enzalutamide," "abiraterone," "treatment sequencing," "cabazitaxel," "docetaxel." A total of 17 studies were included for analysis., Results: Different sequences have been reported for the treatment of mCRPC: docetaxel after abiraterone, cabazitaxel after docetaxel and abiraterone, abiraterone after cabazitaxel and docetaxel, abiraterone after docetaxel and enzalutamide, and enzalutamide after docetaxel and abiraterone. There are arguments from the preclinical observations suggesting a cross-resistance between docetaxel and abiraterone, and between abiraterone and enzalutamide in mCRPC. Despite limitations, several retrospective clinical reports support these data., Conclusion: No study of high level of evidence is available to support any recommendation on sequential treatment for mCRPC. There are only clues that prospective clinical studies need to confirm.
- Published
- 2016
- Full Text
- View/download PDF
165. [Not Available].
- Author
-
May A, Bergot C, Boutin J, Branchereau J, Karam G, and Bruyere F
- Published
- 2015
- Full Text
- View/download PDF
166. Technical feasibility of robot-assisted laparoscopic radical prostatectomy in renal transplant recipients: Results of a series of 12 consecutive cases.
- Author
-
Le Clerc QC, Lecornet E, Leon G, Rigaud J, Glemain P, Branchereau J, and Karam G
- Abstract
Introduction: We evaluate the technical feasibility of robotic prostatectomy in renal transplant recipients., Methods: We retrospectively analyzed preoperative and perioperative settings, as well as functional and oncologic results of 12 patients operated on between 2009 and 2013. Prostatectomy was performed via a transperitoneal approach without any changing in the ports position. The average age was 61.92 ± 2.98 years. The period between transplant and the diagnosis of adenocarcinoma was 79.7 months. The mean PSA was 7.34 ng/mL (range: 4.9-11)., Results: The operative time was 241.3 ± 35.6 minutes with only one conversion and one transfusion. The intervention was difficult due to adhesions on the side of the graft in 50% of cases. There was a case of obstructive acute renal failure resulting from a hematoma of the Retzius treated by percutaneous nephrostomy at D20. There was a majority of pT2c (72.7%), including 3 positive margins (27.3%) and 2 biochemical relapses treated with radiotherapy and hormonotherapy, respectively. The end point prostate-specific antigen was undetectable. There was no significant difference between preoperative and J7 creatinine (p = 0. 22)., Conclusions: Robotic prostatectomy in renal transplant recipients is a safe technique with no serious effects on the allograft.
- Published
- 2015
- Full Text
- View/download PDF
167. Bortezomib, C1-inhibitor and plasma exchange do not prolong the survival of multi-transgenic GalT-KO pig kidney xenografts in baboons.
- Author
-
Le Bas-Bernardet S, Tillou X, Branchereau J, Dilek N, Poirier N, Châtelais M, Charreau B, Minault D, Hervouet J, Renaudin K, Crossan C, Scobie L, Takeuchi Y, Diswall M, Breimer ME, Klar N, Daha MR, Simioni P, Robson SC, Nottle MB, Salvaris EJ, Cowan PJ, d'Apice AJ, Sachs DH, Yamada K, Lagutina I, Duchi R, Perota A, Lazzari G, Galli C, Cozzi E, Soulillou JP, Vanhove B, and Blancho G
- Subjects
- Animals, Animals, Genetically Modified, Autoimmune Diseases, Bortezomib, Cytomegalovirus physiology, Galactosyltransferases deficiency, Gene Knockout Techniques, Immunity, Innate physiology, Immunosuppressive Agents therapeutic use, Kidney surgery, Kidney virology, Models, Animal, Papio anubis, Sus scrofa, Virus Replication physiology, Boronic Acids therapeutic use, Complement C1 Inhibitor Protein therapeutic use, Galactosyltransferases genetics, Graft Survival physiology, Heterografts, Kidney Transplantation, Plasma Exchange, Pyrazines therapeutic use
- Abstract
Galactosyl-transferase KO (GalT-KO) pigs represent a potential solution to xenograft rejection, particularly in the context of additional genetic modifications. We have performed life supporting kidney xenotransplantation into baboons utilizing GalT-KO pigs transgenic for human CD55/CD59/CD39/HT. Baboons received tacrolimus, mycophenolate mofetil, corticosteroids and recombinant human C1 inhibitor combined with cyclophosphamide or bortezomib with or without 2-3 plasma exchanges. One baboon received a control GalT-KO xenograft with the latter immunosuppression. All immunosuppressed baboons rejected the xenografts between days 9 and 15 with signs of acute humoral rejection, in contrast to untreated controls (n = 2) that lost their grafts on days 3 and 4. Immunofluorescence analyses showed deposition of IgM, C3, C5b-9 in rejected grafts, without C4d staining, indicating classical complement pathway blockade but alternate pathway activation. Moreover, rejected organs exhibited predominantly monocyte/macrophage infiltration with minimal lymphocyte representation. None of the recipients showed any signs of porcine endogenous retrovirus transmission but some showed evidence of porcine cytomegalovirus (PCMV) replication within the xenografts. Our work indicates that the addition of bortezomib and plasma exchange to the immunosuppressive regimen did not significantly prolong the survival of multi-transgenic GalT-KO renal xenografts. Non-Gal antibodies, the alternative complement pathway, innate mechanisms with monocyte activation and PCMV replication may have contributed to rejection., (© Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.)
- Published
- 2015
- Full Text
- View/download PDF
168. FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft.
- Author
-
Poirier N, Dilek N, Mary C, Ville S, Coulon F, Branchereau J, Tillou X, Charpy V, Pengam S, Nerriere-Daguin V, Hervouet J, Minault D, Le Bas-Bernardet S, Renaudin K, Vanhove B, and Blancho G
- Subjects
- Animals, Blotting, Western, Cells, Cultured, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Graft Rejection drug therapy, Graft Survival drug effects, Immunoenzyme Techniques, Immunosuppression Therapy, Kidney Diseases immunology, Kidney Diseases surgery, Papio, RNA, Messenger genetics, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, T-Lymphocytes, Regulatory immunology, Transplantation, Homologous, CD28 Antigens immunology, Calcineurin Inhibitors pharmacology, Graft Rejection immunology, Graft Survival immunology, Immunization, Immunoglobulin Fab Fragments pharmacology, Kidney Transplantation
- Abstract
Selective targeting of CD28 might represent an effective immunomodulation strategy by preventing T cell costimulation, while favoring coinhibition since inhibitory signals transmitted through CTLA-4; PD-L1 and B7 would not be affected. We previously showed in vitro and in vivo that anti-CD28 antagonists suppress effector T cells while enhancing regulatory T cell (Treg) suppression and immune tolerance. Here, we evaluate FR104, a novel antagonist pegylated anti-CD28 Fab' antibody fragment, in nonhuman primate renal allotransplantation. FR104, in association with low doses of tacrolimus or with rapamycin in a steroid-free therapy, prevents acute rejection and alloantibody development and prolongs allograft survival. However, when FR104 was associated with mycophenolate mofetil and steroids, half of the recipients rejected their grafts prematurely. Finally, we observed an accumulation of Helios-negative Tregs in the blood and within the graft after FR104 therapy, confirmed by Treg-specific demethylated region DNA analysis. In conclusion, FR104 reinforces immunosuppression in calcineurin inhibitor (CNI)-low or CNI-free protocols, without the need of steroids. Accumulation of intragraft Tregs suggested the promotion of immunoregulatory mechanisms. Selective CD28 antagonists might become an alternative CNI-sparing strategy to B7 antagonists for kidney transplant recipients., (© Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.)
- Published
- 2015
- Full Text
- View/download PDF
169. Multi detector computed tomography (MDCT) for the diagnosis of early complications after pancreas transplantation.
- Author
-
Vincent M, Morla O, Branchereau J, Karam G, Dupas B, and Frampas E
- Subjects
- Adult, Contrast Media, Female, Hemorrhage diagnostic imaging, Humans, Male, Middle Aged, Pancreas diagnostic imaging, Radiographic Image Enhancement methods, Retrospective Studies, Risk Factors, Thrombosis diagnostic imaging, Venous Thrombosis diagnostic imaging, Young Adult, Multidetector Computed Tomography methods, Pancreas Transplantation, Postoperative Complications diagnostic imaging
- Abstract
Purpose: Solitary Pancreas (SPT) and simultaneous kidney-pancreas (SPKT) transplants carry a high risk of surgical complications that may lead to the loss of the pancreas graft and impact later kidney function. The purpose of this study was to investigate the role of MDCT in the diagnosis of early complications and its impact on kidney function., Methods: All patients receiving SPT or SPKT over 5 years were retrospectively included. Complications that occurred within the first 15 days were registered and MDCT data analyzed. Data regarding donor, transplant, and recipient characteristics as well as transplantation procedures were analyzed according to the occurrence of early complications. Kidney function at day 3 following MDCT was evaluated., Results: One hundred and forty-one patients were included (85 men, 56 women; mean age 40.1 years, SD 7.7) with 119 SPKT and 22 SPT. Sixty-four complications were registered in 50 patients. Partial (P-) or complete venous thrombosis (C-VT) occurred in 12.1 % (n = 17), arterial thrombosis (AT) in 1.4 % (n = 2), and hemorrhage in 8.5 % (n = 12) of all patients. For venous thrombosis, the predominant risk factor was body mass index (BMI) for either recipients (P < 0.05) or donors (P < 0.01). Median time for venous thrombosis diagnosis with MDCT was 4 days. Kidney function was not altered following MDCT. Fourteen pancreatectomies were necessary. All patients with C-VT and AT had to undergo graftectomy., Conclusion: Vascular complications occurred early following grafting. Systematic early-enhanced MDCT at day 2-3 should be adequate to detect early thrombosis, especially if risk factors have been identified, without induced kidney function alteration.
- Published
- 2014
- Full Text
- View/download PDF
170. Pharmacological strategy designed to limit ischemia-reperfusion injury in brain dead donor kidneys.
- Author
-
Branchereau J and Barrou B
- Subjects
- Brain Death, Chemoprevention, Humans, Tissue Donors, Kidney blood supply, Kidney Transplantation, Reperfusion Injury prevention & control
- Abstract
Ischemia-reperfusion injury is a complex physiological process responsible for delayed renal function or primary graft non-function, explicitly when kidney allograft are issued from expanded criteria donor. The purpose of this review is to detail the detrimental phenomenons altering kidney allograft's integrity in brain dead donor, therefore suggesting pharmacological interventions aiming to reduce ischemia-reperfusion injuries and improving transplantation outcome. This ischemia-reperfusion phenomenon must therefore be anticipated through the whole procedure starting at the stage of conditioning of the potential donor. Hormonal and haemodynamic consequences of brain death modify perfusion and oxygenation conditions of the organs Thus, after describing the autonomic, metabolic, endocrine and chemokine storm occurring during brain death, the authors focus on strategies to prevent hemodynamic instability in the donor and to limit the consequences of hormonal and immunological changes on organs that will eventually be transplanted., (Copyright © 2014 Elsevier Masson SAS. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
171. [Prostatic stromal tumors of uncertain malignant potential (STUMP): a case report].
- Author
-
Michaud S, Moreau A, Braud G, Renaudin K, Branchereau J, Bouchot O, and Rigaud J
- Subjects
- Adenocarcinoma diagnosis, Diagnosis, Differential, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Phyllodes Tumor classification, Phyllodes Tumor diagnosis, Phyllodes Tumor surgery, Prostatectomy, Prostatic Hyperplasia diagnosis, Prostatic Neoplasms classification, Prostatic Neoplasms diagnosis, Prostatic Neoplasms surgery, Sarcoma diagnosis, Phyllodes Tumor pathology, Prostatic Neoplasms pathology, Stromal Cells pathology
- Abstract
We report the case of a patient affected by a voluminous prostatic tumor for which the histological analysis conclude in a stromal tumor of uncertain malignant potential. This type of tumor is rare, but requires to be individualized to differentiate it from a benign prostatic hyperplasia or a sarcoma of the prostate. The therapeutic care must be made keeping in mind the risk of degeneration towards a malignant shape., (Copyright © 2014 Elsevier Masson SAS. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
172. [Renal colic in pregnancy: series of 103 cases].
- Author
-
Fontaine-Poitrineau C, Branchereau J, Rigaud J, Bouchot O, Caroit-Cambazard Y, and Glémain P
- Subjects
- Adolescent, Adult, Analgesics therapeutic use, Anti-Bacterial Agents therapeutic use, Female, Humans, Kidney Calculi complications, Kidney Calculi diagnosis, Pregnancy, Retrospective Studies, Urinary Tract Infections complications, Urinary Tract Infections diagnosis, Young Adult, Pregnancy Complications etiology, Pregnancy Complications therapy, Renal Colic etiology, Renal Colic therapy
- Abstract
Purpose: To evaluate the management of renal colic in pregnant woman in our hospital., Material and Methods: A retrospective study of 103 pregnant patients, hospitalized for back pain of renal colic type, associated or not with a urinary tract infection, between January 2005 and October 2010. Three groups of patients were identified from the initial clinical and paraclinical (ultrasound). Group I involved patients with dilatation of the renal cavities associated with septic syndrome, they received analgesic treatment and empiric antibiotic therapy. Group II involved patients with dilatation of the renal cavities isolated, without fever, they received only analgesic treatment. Group III involved patients without dilatation of the renal cavities, they received analgesic treatment and antibiotics in case of fever, and then another cause of pain was sought., Results: The renal colic was due to a stone in 19.4 % of cases. A urinary infection was associated in 28 % of patients. Ultrasond was sufficient to confirm the diagnosis in 96 % of cases. In 4 % of cases, MRI or low-dose CT were necessary. Therapeutic management based on analgesic treatment, associated with probabilistic antibiotherapy or adapted in case of documented infection, allowed sedation of pain in two-third of cases. In case of failure or signs of severity, the urinary diversion by a double J stent was efficient, without consequences on pregnancy issue. One stone was treated by ureteroscopy during pregnancy without complication., Conclusion: The management of renal colic in pregnant woman based on ultrasound diagnosis, symptomatic treatment and urinary diversion by double J stent in case of failure therefore seemed quite sure on mother and fetus., (Copyright © 2013 Elsevier Masson SAS. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
173. [Corticotherapy in castration-resistant prostate cancer].
- Author
-
Lebdai S, Branchereau J, Robert G, De La Taille A, and Bouchaert P
- Subjects
- Androstenes, Androstenols therapeutic use, Antineoplastic Agents therapeutic use, Apoptosis drug effects, Clinical Trials as Topic, Drug Therapy, Combination, Glucocorticoids administration & dosage, Glucocorticoids adverse effects, Humans, Inflammation drug therapy, Male, Neovascularization, Pathologic drug therapy, Prostatic Neoplasms, Castration-Resistant pathology, Receptors, Glucocorticoid drug effects, Survival Analysis, Treatment Outcome, Glucocorticoids therapeutic use, Prostate-Specific Antigen drug effects, Prostatic Neoplasms, Castration-Resistant drug therapy
- Abstract
Introduction: Corticosteroids are commonly used in the treatment of prostate cancer resistant to castration (PCRC), partly due to the inhibitory effects on adrenal androgen production acting as a pituitary suppressant., Methods: A literature search was conducted in PubMed/MEDLINE database using the following key words: prostate cancer; castration resistance; metastasis; corticotherapy., Results: Corticosteroids exert direct anti-tumoral activities mediated by the glucocorticoids receptor and involving cellular/tissue functions as growth, apoptosis, inflammation, metastasis, differentiation and angiogenesis. As a pain relieving agents, corticosteroids significantly relieve PCRC clinical symptoms, especially those due to bone metastasis. In the comparative arm of phase II-III trials, corticosteroids administered daily produce a PSA decline. Among the adverse effects due to corticosteroids, bone loss and cardiovascular risk should be carefully monitored. In association with abiraterone acetate, corticosteroids increase overall survival in PCRC patients, and reduce the mineralocorticoid side effects of abiraterone., Conclusion: Corticosteroids in monotherapy for PCRC have a limited efficacy. In association with abiraterone acetate it reduces the mineralocorticoid toxicity and enhances the androgenic suppression., (Copyright © 2013 Elsevier Masson SAS. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
174. [Qualitative and quantitative hormonal regulation in castration-resistant prostate cancer].
- Author
-
Murez T, Basset V, Audenet F, Lebret T, and Branchereau J
- Subjects
- Dihydrotestosterone metabolism, Disease Progression, Humans, Male, Neoplasm Recurrence, Local pathology, Prostatic Neoplasms, Castration-Resistant pathology, Treatment Outcome, Androgen Antagonists therapeutic use, Androgens metabolism, Antineoplastic Agents, Hormonal therapeutic use, Neoplasm Recurrence, Local drug therapy, Neoplasm Recurrence, Local metabolism, Prostatic Neoplasms, Castration-Resistant drug therapy, Prostatic Neoplasms, Castration-Resistant metabolism
- Abstract
Introduction: Despite initial sensitivity to androgen deprivation, most metastatic prostate cancer patients will experience recurrence or progression. This evolution, which occurs while seric testosterone level is low, is called castration resistant prostate cancer (CRPC)., Material and Methods: MEDLINE database was requested for French or English articles published until September 2012 responding to the following keywords: "castration resistant", "prostatic neoplasms", "androgens", "testosterone", "regulat*". Here is a summary of relevant data concerning both qualitative and quantitative hormonal regulation., Results: androgen blood testing is not related to tissue concentrations, as prostate cancer cells exhibit higher hormones levels. Despite its higher biological efficiency, dihydrotestosterone is not the only mediator of androgen-dependent transcription. Androgen synthesis implies many pathways including lot of alternative ones. Steroïdogenesis can occur out of the testicles and the adrenals, and maybe in tumor cell or tissue. Major and minor androgens levels, as those of co-repressors and activators inside the tumor cell leads to a smooth androgen activity modulation. Many drugs have the ability to block those different steps., Conclusion: Castration resistance reflects an androgen activity in tumor cells while major androgen pathway activators are lowered. Alternate pathway include steroids pumps, de novo synthesis by tumor cells or their environment, minor androgens activation by co-factors regulation. Many drugs are known to inhibit those escaping ways. Nowadays they are not efficient enough, because of other minor pathways becoming dominant. Investigations are required but would need new detection techniques of low androgen concentrations in blood as in tissues., (Copyright © 2013 Elsevier Masson SAS. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
175. 18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study.
- Author
-
Hitier-Berthault M, Ansquer C, Branchereau J, Renaudin K, Bodere F, Bouchot O, and Rigaud J
- Subjects
- Adenocarcinoma diagnosis, Adenocarcinoma secondary, Adenocarcinoma surgery, Fluorodeoxyglucose F18, Lymph Node Excision, Lymphatic Metastasis pathology, Multimodal Imaging standards, Neoplasm Staging methods, Pilot Projects, Positron-Emission Tomography standards, Preoperative Care methods, Prospective Studies, Radiopharmaceuticals, Reproducibility of Results, Sensitivity and Specificity, Tomography, X-Ray Computed standards, Carcinoma, Squamous Cell diagnosis, Carcinoma, Squamous Cell secondary, Carcinoma, Squamous Cell surgery, Cystectomy, Multimodal Imaging methods, Positron-Emission Tomography methods, Tomography, X-Ray Computed methods, Urinary Bladder Neoplasms diagnosis, Urinary Bladder Neoplasms secondary, Urinary Bladder Neoplasms surgery
- Abstract
Objectives: The objective of our study was to analyze the diagnostic performance of (18) F-fluorodeoxyglucose positron emission tomography-computed tomography for lymph node staging in patients with bladder cancer before radical cystectomy and to compare it with that of computed tomography., Methods: A total of 52 patients operated on between 2005 and 2010 were prospectively included in this prospective, mono-institutional, open, non-randomized pilot study. Patients who had received neoadjuvant chemotherapy or radiotherapy were excluded. (18) F-fluorodeoxyglucose positron emission tomography-computed tomography in addition to computed tomography was carried out for lymph node staging of bladder cancer before radical cystectomy. Lymph node dissection during radical cystectomy was carried out. Findings from (18) F-fluorodeoxyglucose positron emission tomography-computed tomography and computed tomography were compared with the results of definitive histological examination of the lymph node dissection. The diagnostic performance of the two imaging modalities was assessed and compared., Results: The mean number of lymph nodes removed during lymph node dissection was 16.5 ± 10.9. Lymph node metastasis was confirmed on histological examination in 22 cases (42.3%). This had been suspected in five cases (9.6%) on computed tomography and in 12 cases (23.1%) on (18) F-fluorodeoxyglucose positron emission tomography-computed tomography. Sensitivity, specificity, positive predictive value, negative predictive value, relative risk and accuracy were 9.1%, 90%, 40%, 57.4%, 0.91 and 55.7%, respectively, for computed tomography, and 36.4%, 86.7%, 66.7%, 65%, 2.72, 65.4%, respectively, for (18) F-fluorodeoxyglucose positron emission tomography-computed tomography., Conclusions: (18) F-fluorodeoxyglucose positron emission tomography-computed tomography is more reliable than computed tomography for preoperative lymph node staging in patients with invasive bladder carcinoma undergoing radical cystectomy., (© 2012 The Japanese Urological Association.)
- Published
- 2013
- Full Text
- View/download PDF
176. Prognostic value of the lymphovascular invasion in high-grade stage pT1 bladder cancer.
- Author
-
Branchereau J, Larue S, Vayleux B, Karam G, Bouchot O, and Rigaud J
- Subjects
- Aged, Disease-Free Survival, Female, Humans, Male, Neoplasm Grading, Neoplasm Recurrence, Local, Neoplasm Staging, Prognosis, Retrospective Studies, Survival Rate, Urinary Bladder Neoplasms pathology, Urinary Bladder Neoplasms surgery, Cystectomy, Lymphatic Metastasis, Urinary Bladder Neoplasms mortality
- Abstract
Purpose: High-grade (HG) stage pT1 bladder cancers have the highest recurrence and progression rates of all non-muscle-invasive bladder cancers. Some prognostic factors for recurrence and progression have been identified: multifocal HG pT1, concomitant carcinome in situ, tumor diameter >3 cm, infiltration of the deep lamina propria, and persistence of pT1 tumor on a second transurethral resection of the bladder. The objective of this study was to determine whether the presence of lymphovascular invasion (LVI) is also a prognostic factor that must be taken into account., Materials and Methods: This retrospective study was performed with 108 patients with HG stage pT1 bladder cancer: 89 patients were treated conservatively (transurethral resection of the bladder plus bacille Calmette-Guérin therapy), and 19 patients underwent early cystectomy. The mean (SD) follow-up was 47.8 ± 41.2 months. Classic prognostic factors and LVI were analyzed in terms of overall survival, specific survival, recurrence-free survival, and progression-free survival., Results: Thirty-six percent of patients had LVI on the chips of the first transurethral resection of the bladder. Five-year overall survival and specific survival were 40% and 75%, respectively. Multivariate analysis of risk factors showed a significant reduction of overall survival in the presence of LVI (P = .007). The presence of LVI was also a factor of poor prognosis in the case of delayed cystectomy (P = .010) but not in the case of early cystectomy., Conclusions: Identification of LVI on the first resection of a HG stage pT1 bladder cancer is a significant prognostic factor for overall survival., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
177. [A majority of useless call of an on-call urology resident: a study of the AFUF].
- Author
-
Koutlidis N, Fiard G, Brichart N, Souillac I, Lebacle C, Cerruti A, Terrasa JB, Bigot P, Branchereau J, Celhay O, Ripert T, Terrier JE, Beauval JB, Murez T, Fais PO, and Bessede T
- Subjects
- Humans, Prospective Studies, Surveys and Questionnaires, Emergency Service, Hospital statistics & numerical data, Emergency Treatment statistics & numerical data, Internship and Residency, Urology, Workload
- Abstract
Goal: To assess the workload of an on-call urology resident at a French University Hospital., Material: A prospective study was performed during 15 days in February 2012. The data recorded in our database regarded the resident (sex, age, time to go to work), the call (emergency, type and reason) and the person who called (grade, department)., Results: Seven centres including 18 residents participated. On average five calls were received per day [0-17]. After midnight, the resident was called less than twice (1.6). There was an actual emergency in 64% of cases [0-13]. The urology-related call motives (73%) mainly consisted in acute urine retention (AUR) and catheter problems (73), renal colic (RC) (49), acute pyelonephritis (23), and hematuria (22). Residents had to go to the hospital in 55% of AUR and catheter problems, 30% of acute pyelonephritis, 17% of RC and 14% of hematuria. The emergency department (ED) called the urology resident in 39% of cases but only 18% required the presence of the resident. A call made by a senior was more likely to be an emergency (67%) than by a resident or a nurse (51%, P=0.02)., Conclusion: The urology resident when on-call is mainly asked for an advice by the ED. Among urology-related advice, bladder catheterization problems were the most frequent. RC was the second call motive but most of the time was not an actual emergency., (Copyright © 2013 Elsevier Masson SAS. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
178. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
- Author
-
Gigante M, Neuzillet Y, Patard JJ, Tillou X, Thuret R, Branchereau J, Timsit MO, Terrier N, Boutin JM, Sallusto F, Karam G, Barrou B, Chevallier D, Mazzola CR, Delaporte V, Doeffler A, Kleinclauss F, and Badet L
- Subjects
- Carcinoma, Renal Cell etiology, Carcinoma, Renal Cell pathology, Female, France epidemiology, Humans, Kidney Failure, Chronic epidemiology, Kidney Failure, Chronic therapy, Kidney Neoplasms etiology, Kidney Neoplasms pathology, Male, Middle Aged, Neoplasm Staging methods, Prevalence, Prognosis, Retrospective Studies, Risk Factors, Survival Rate trends, Carcinoma, Renal Cell epidemiology, Kidney Failure, Chronic complications, Kidney Neoplasms epidemiology, Kidney Transplantation, Renal Dialysis
- Abstract
Unlabelled: What's known on the subject? and What does the study add? Patients with end-stage renal disease (ESRD) have an increased risk of developing RCC in their native kidneys. The prevalence of RCC is 3-4% in cases of ESRD in dialyzed and/or transplanted patients, which corresponds to a rate 100-times higher than that in the general population. This is the first study, to our knowledge, comparing the characteristics of kidney cancer in the ESRD population according to their dialysis or transplantation status at the time of diagnosis. The differences in stage and survival we observed may be due to differences in surveillance strategies between transplanted and not transplanted patients, nevertheless, the differences in pathological subtypes suggest they could also be due to differences in the tumorigenesis process., Objective: • To compare clinical, pathological and outcome features of renal cell carcinomas (RCCs) arising in patients with chronic renal failure (CRF) with or without renal transplantation., Patients and Methods: • In all, 24 French University Departments of Urology and Kidney Transplantation participated in this retrospective study comparing RCCs arising in patients with CRF according to their dialysis or transplantation status at the time of diagnosis. • Information about age, sex, symptoms, duration of CRF, mode and duration of dialysis, renal transplantation, tumour staging and grading, histological subtype and outcome were recorded in a unique database. • Qualitative and quantitative variables were compared by using chi-square and Student statistical analysis. Survival was assessed by Kaplan-Meier and Cox methods., Results: • Data on 303 RCC cases diagnosed between 1985 and 2009 were identified in 206 men (76.3%) and 64 women (23.7%). • Transplanted and not transplanted patients accounted for 213 (70.3%) and 90 cases (29.7%), respectively. • In transplant recipients, RCC was diagnosed at a younger age [mean (sd) 53 (11) vs 61 (14) years, P < 0.001), the mean tumour size was smaller [3.4 (2.3) vs 4.2 (3.1) cm, P= 0.02), pT1a stage (75 vs 60%, P= 0.009) and papillary histological subtype (44 vs 22%, P < 0.001) were more frequent than in their dialysis-only counterparts. • Nodal (1 vs 6%, P= 0.03) and distant metastases rates (0 vs 5%, P < 0.001) were significantly increased in patients who had not had a transplant. However, Fürhman grading, symptoms, tumour multifocality or bilaterality, presence of acquired cystic kidney disease, were not significantly different between the groups. • Estimated 5-year survival rates were 97% and 77% for transplanted and not transplanted patients, respectively (P < 0.001). In univariate analysis, presence of symptoms (P= 0.008), poor performance status (P= 0.04), large tumour size, advanced TNM stage (P < 0.001), high Führman grade (P= 0.005) and absence of transplantation (P < 0.001) were all adverse prognostic factors. In multivariate analysis, only T stage remained an independent predictor for cancer-related death (P < 0.001)., Conclusion: • RCC arising in native kidneys of transplant patients seems to exhibit many favourable clinical, pathological and outcome features compared with those diagnosed in dialysis-only patients. Further research is needed to determine whether it is due to particular molecular pathways or to biases in relation to mode of diagnosis., (© 2012 BJU INTERNATIONAL.)
- Published
- 2012
- Full Text
- View/download PDF
179. [Kidney transplantation in obese recipients: review of the Transplantation Committee of the French Association of Urology].
- Author
-
Thuret R, Tillou X, Doerfler A, Sallusto F, Branchereau J, Terrier N, Boutin JM, Gigante M, Neuzillet Y, Kleinclauss F, Badet L, and Timsit MO
- Subjects
- Graft Rejection, Graft Survival, Humans, Patient Selection, Renal Insufficiency mortality, Kidney Transplantation mortality, Obesity complications, Postoperative Complications, Renal Insufficiency surgery
- Abstract
Introduction: Transplantation Committee of the French Association of Urology (CTAFU) conducted a review of the complication of kidney transplantation in obese recipients., Material and Methods: A bibliographic research in French and English using Medline with the keywords "obesity", "body mass index", "kidney transplantation", "graft function", "survival", "wound complications", "graft rejection" and "graft survival" was performed. We limited the review for the last fifteen years because of the change in immunosuppressive treatment area. Only studies with more than 20 obese patients were selected., Results: Wound or infectious postoperative complications and delayed graft function are more frequent in obese patients than in non-obese recipients. Similarly, transplant survival at 5 years is lower in obese patients. On the other hand, patient survival and acute rejection are the same between the two groups if recipient selection is carefully made, particularly with regard to heart complication., Conclusion: Kidney transplantation in obese patients is not an easy surgery with known complication. Obese patients will take time before transplantation to explain all the risk and a regular heart follow-up is crucial if we don't want to reduce patient survival. But obese survival is better if we proceed to kidney transplantation than if they stay on dialysis, arguing for a non-exclusion of the waiting list. So there is the need for a national study concerning obese patients on waiting list to enact future guidelines., (Copyright © 2012 Elsevier Masson SAS. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
180. [Prostatic Stromal Tumors of Uncertain Malignant Potential (STUMP): definition, pathology, prognosis and management].
- Author
-
Michaud S, Moreau A, Braud G, Renaudin K, Branchereau J, Bouchot O, and Rigaud J
- Subjects
- Humans, Male, Prostatectomy, Prostatic Hyperplasia surgery, Prostatic Neoplasms surgery, Sarcoma pathology, Sarcoma surgery, Prostatic Hyperplasia pathology, Prostatic Neoplasms pathology, Stromal Cells pathology
- Abstract
Prostatic Stromal Tumors of Uncertain Malignant Potential (STUMP) are rare tumor of the prostate of mesenchymal origin, accounting, with sarcoma for 0.1-0.2% of all malignant prostatic tumours. They however require to be individualized, to differentiate it from a benign prostatic hyperplasia or a sarcoma of the prostate. The therapeutic management should be made keeping in mind the risk of degeneration towards a malignant shape. Although the appropriate treatment is unknown, radical prostatectomy seem to be the treatment of reference, especially for young patient or for extensive lesion., (Copyright © 2012 Elsevier Masson SAS. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
181. [Pelvic radiotherapy and artificial urinary sphincter in women].
- Author
-
Vayleux B, Rigaud J, Branchereau J, Larue S, Karam G, Glémain P, Bouchot O, and Le Normand L
- Subjects
- Female, Follow-Up Studies, Humans, Middle Aged, Postoperative Complications, Retrospective Studies, Urinary Incontinence, Stress surgery, Urinary Sphincter, Artificial, Uterine Cervical Neoplasms radiotherapy
- Abstract
Objectives: A retrospective evaluation of artificial urinary sphincter (AUS) implantation in women with previous pelvic radiotherapy (PR)., Population and Methods: From May 1987 to December 2009, on the 215 women implanted with AUS, nine (4.2%) had previous PR. We compared two groups of women, the first one without PR (group 1; n=206) and the other group with PR (group 2; n=9). Previous preop. urodynamics were realized. Patients using more than one pad per day at the end of follow-up were considered in failure., Results: Mean follow-up for these two groups was 6 years (SD: 5.6 years), with a mean age of 62.8 years. Mean delay between PR and surgery was 14 years. PR was indicated for cervix cancer in 78% (7/9), endometrial cancer and ovarian cancer in 9% (1/9) each. PR was responsible of an increased rate of AUS erosion and explantation (P<0.001). In group 2, more than half of women had AUS failure and 60% for AUS erosion, versus 22% and 26% respectively in group 1. In group 2, all the AUS eroded were explanted, one third of women, with a mean delay of 59.8 months (4-140) with AUS implantation., Conclusion: AUS implantation in a female population with previous PR is not necessary inconsistent, but the failure rate is high. This difficult surgery should be reserved for specialized centres., (Copyright © 2012 Elsevier Masson SAS. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
182. [Pancreas transplantation and venous thrombosis: multivariate analysis of risk factors].
- Author
-
Deboudt C, Branchereau J, Luyckx F, Rigaud J, Glemain P, Blancho G, and Karam G
- Subjects
- Adult, Female, Humans, Male, Multivariate Analysis, Retrospective Studies, Risk Factors, Venous Thrombosis epidemiology, Pancreas Transplantation adverse effects, Venous Thrombosis etiology
- Abstract
Objective: Portal veinous thrombosis (VT) in the pancreatic transplant (6 to 20% of the cases) is the first cause of early loss of the transplant. Our objective was to identify the risk factors of VT in our experiment., Method: The sample group includes 106 patients who underwent pancreas transplantation (portal venous drainage, enteric-drained pancreas) within our institute of transplantation from 2004 until 2010. We completed a portal vein extension graft in 25% of the cases. First of all, risk factors were selected from preoperative and operative data with an univariate analysis. We then carried out a multivariate analysis of these factors (binary logistic regression). The threshold P was 0.05., Results: Sixteen patients (15%) showed a VT. Eight of them developed a total thrombosis and required a transplantectomy. Three risk factors of VT were isolated by the multivariate analysis: a BMI of the receiver>25kg/m(2) (Odds Ratio [OR]=6.977), a portal vein extension graft (OR=4.1) and an age of the donor>45 years (OR=4.432)., Conclusions: The knowledge of these risk factors of thrombosis allows the implementation of preventive measures (selection of the donor, nutritional support of the receiver in the registration if BMI>25kg/m(2)). The portal lengthening should be avoided by an attentive retrieval of the transplant (without shorter section of the portal vein). Nevertheless, the presence of one of these risk factors in a transplant patient should lead to start an antithrombotic treatment., (Copyright © 2012 Elsevier Masson SAS. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
183. [Alert on the predictable accessibility of the fellowship of urology until 2013: a study of the AFUF].
- Author
-
Celhay O, d'Arcier BF, Koutlidis N, Beauval JB, Benschik A, Bernhard JC, Bigot P, Branchereau J, Brichart N, Colin P, Fais PO, Guillotreau J, Mazola C, Murez T, Pignot G, Rippert T, Rouache L, Souillac I, Terrasa JB, Terrier JE, Xylinas E, and Bessede T
- Subjects
- France, Fellowships and Scholarships statistics & numerical data, Internship and Residency statistics & numerical data, Urology education
- Abstract
Purpose: To evaluate the accessibility of the fellowship for the residents of Urology expecting to accomplish their residentship between November 2010 and 2013., Patients: Between November 2010 and January 2011, all the residents ongoing for the residentship of Urology in France were reached by an electronic mailing using the AFUF register. A questionnaire reported all the residents expecting to accomplish their residentship between November 2010 and 2013, and the number and the expected availability of fellow and specialist assistant posts during the same period., Results: Our study counted 306 urologists on training (190 residents, 76 fellows, 30 assistants, 10 on other posts). On November 2010, 56 residents accomplished their residentship, while 68 and 79 residents expected to accomplish their residentship on November 2011 and 2012, respectively. One hundred and six posts validated the fellowship of Urology on November 2010 (76 fellows, 30 assistants), among 54 posts were available. Over the residents expecting to accomplish their residentship on November 2011 and 2012, 22 and 54 residents may not find a fellow post available., Conclusion: The number of residents expecting to accomplish the residentship of Urology between November 2010 and 2013 was increasing, showing a greater interest for this speciality and a lack of regulation for its accessibility. By reason of a discrepancy of fellow and specialist assistant posts, only 67.6 and 31.6% of the residents expecting to accomplish their residentship on November 2011 and 2012 may be able to find a post available., (Copyright © 2011 Elsevier Masson SAS. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
184. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
- Author
-
Neuzillet Y, Tillou X, Mathieu R, Long JA, Gigante M, Paparel P, Poissonnier L, Baumert H, Escudier B, Lang H, Rioux-Leclercq N, Bigot P, Bernhard JC, Albiges L, Bastien L, Petit J, Saint F, Bruyere F, Boutin JM, Brichart N, Karam G, Branchereau J, Ferriere JM, Wallerand H, Barbet S, Elkentaoui H, Hubert J, Feuillu B, Theveniaud PE, Villers A, Zini L, Descazeaux A, Roupret M, Barrou B, Fehri K, Lebret T, Tostain J, Terrier JE, Terrier N, Martin L, Dugardin F, Galliot I, Staerman F, Azemar MD, Irani J, Tisserand B, Timsit MO, Sallusto F, Rischmann P, Guy L, Valeri A, Deruelle C, Azzouzi AR, Chautard D, Mejean A, Salomon L, Rigaud J, Pfister C, Soulié M, Kleinclauss F, Badet L, and Patard JJ
- Subjects
- Adult, Aged, Carcinoma, Renal Cell mortality, Carcinoma, Renal Cell pathology, Carcinoma, Renal Cell therapy, Chi-Square Distribution, Female, France, Humans, Kaplan-Meier Estimate, Kidney Failure, Chronic mortality, Kidney Failure, Chronic therapy, Kidney Neoplasms mortality, Kidney Neoplasms pathology, Kidney Neoplasms therapy, Male, Middle Aged, Neoplasm Staging, Proportional Hazards Models, Retrospective Studies, Risk Assessment, Risk Factors, Survival Rate, Time Factors, Treatment Outcome, Carcinoma, Renal Cell etiology, Kidney Failure, Chronic complications, Kidney Neoplasms etiology
- Abstract
Background: Patients with end-stage renal disease (ESRD) are at risk of developing renal tumours., Objective: Compare clinical, pathologic, and outcome features of renal cell carcinomas (RCCs) in ESRD patients and in patients from the general population., Design, Setting, and Participants: Twenty-four French university departments of urology participated in this retrospective study., Intervention: All patients were treated according to current European Association of Urology guidelines., Measurements: Age, sex, symptoms, tumour staging and grading, histologic subtype, and outcome were recorded in a unique database. Categoric and continuous variables were compared by using chi-square and student statistical analyses. Cancer-specific survival (CSS) was assessed by Kaplan-Meier and Cox methods., Results and Limitations: The study included 1250 RCC patients: 303 with ESRD and 947 from the general population. In the ESRD patients, age at diagnosis was younger (55 ± 12 yr vs 62 ± 12 yr); mean tumour size was smaller (3.7 ± 2.6 cm vs 7.3 ± 3.8 cm); asymptomatic (87% vs 44%), low-grade (68% vs 42%), and papillary tumours were more frequent (37% vs 7%); and poor performance status (PS; 24% vs 37%) and advanced T categories (≥ 3) were more rare (10% vs 42%). Consistently, nodal invasion (3% vs 12%) and distant metastases (2% vs 15%) occurred less frequently in ESRD patients. After a median follow-up of 33 mo (range: 1-299 mo), 13 ESRD patients (4.3%), and 261 general population patients (27.6%) had died from cancer. In univariate analysis, histologic subtype, symptoms at diagnosis, poor PS, advanced TNM stage, high Fuhrman grade, large tumour size, and non-ESRD diagnosis context were adverse predictors for survival. However, only PS, TNM stage, and Fuhrman grade remained independent CSS predictors in multivariate analysis. The limitation of this study is related to the retrospective design., Conclusions: RCC arising in native kidneys of ESRD patients seems to exhibit many favourable clinical, pathologic, and outcome features compared with those diagnosed in patients from the general population., (Copyright © 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
185. [Double spinofixation laparoscopic versus laparoscopic robot-assisted: Morbidity, anatomical and functional short-term results].
- Author
-
Larue S, Meurette G, Lehur PA, Leveau E, Branchereau J, Bouchot O, and Rigaud J
- Subjects
- Female, Gynecologic Surgical Procedures methods, Humans, Middle Aged, Retrospective Studies, Time Factors, Treatment Outcome, Urologic Surgical Procedures methods, Laparoscopy methods, Robotics, Uterine Prolapse surgery
- Abstract
Objective: The purpose of our study was to compare the morbidity and the short-term anatomical and functional outcome of the double promontofixation according to the surgical access laparoscopic versus laparoscopic robot-assisted., Methods: Forty-six patients were operated for anterior and posterior promontofixation with two mesh between March 2008 and February 2010, 19 were robot-assisted (PR) and 27 laparoscopic (PL). All the patients were contacted again by telephone to answer a questionnaire estimating the functional results., Results: Both groups (PR vs PL) were comparable in terms of age, score ASA and of surgical histories. There was no difference in terms of hospital stay nor per- and postoperative complications. The mean operating time was significantly more important in the group PR (P=0.049). With a mean follow-up of 10,7±7,8 months (PL) versus 8,8±5,9 months (PR), the anatomical result was good without recurrence in 93,5% of the cases. The rate of recurrence was similar in both groups with three patients who had a cystocele grade 2, two in the group PR and one in the group PL (P=0.411). The urinary and sexual functional results were comparable between both groups with an improvement of the rate of dyspareunia and dysuria. However we observed more postoperative constipation in the group PR (10/19 vs 6/27, P=0.033)., Conclusion: The robot-assisted laparoscopic promontofixation is a reproducible technique with a morbidity and anatomical and functional results comparable to the laparoscopic way., (Copyright © 2011 Elsevier Masson SAS. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
186. [Bladder necrosis after an immediate post-operative mitomycin C instillation].
- Author
-
Branchereau J, Luyckx F, Hitier M, Karam G, Bouchot O, and Rigaud J
- Subjects
- Administration, Intravesical, Aged, Antibiotics, Antineoplastic administration & dosage, Humans, Male, Mitomycin administration & dosage, Necrosis chemically induced, Antibiotics, Antineoplastic adverse effects, Mitomycin adverse effects, Postoperative Complications chemically induced, Postoperative Complications pathology, Urinary Bladder pathology
- Abstract
Administration of intravesical chemotherapy by mitomycin C decreases the risk of recurrence in non-muscle-invasive bladder tumours. We report the case of a man, who presented a full bladder necrosis after an immediate adjuvant mitomycin C instillation. The failure of resection of the necrotic area led us to perform a total cystectomy with an intestinal reconstruction. A review of the literature showed four other cases of necrosis of the bladder or of lower urinary tract. In all cases the rules of early instillation were observed., (Copyright © 2010 Elsevier Masson SAS. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
187. [Goldman Antopol syndrome associated with bilateral congenital severe factor V deficiency].
- Author
-
Branchereau J, Leaute F, Luyckx F, Hitier M, Normand G, Karam G, Bouchot O, and Rigaud J
- Subjects
- Adult, Humans, Male, Severity of Illness Index, Syndrome, Factor V Deficiency congenital, Hematoma complications, Kidney Diseases complications, Kidney Pelvis, Ureteral Diseases complications
- Abstract
Antopol-Goldman lesions are extremely rare. This kind of lesion is a subepithelial pelvic hematoma. This syndrome is certainly of rare occurrence and that is why a differential diagnosis of urothelial cancer in young patients who had problems with clotting must be raised. We reported a case of a 43-year-old haemophiliac with a severe congenital factor V deficit and presenting a bilateral and asynchronous Antopol Goldman syndrome. The diagnosis has been based on CT scans. The subepithelial aetiology bleeding has been shown on selective renal arteriography that allowed to cover a micro-aneurysm through the setting up of a vascular stent and a selective embolization., (Copyright © 2009 Elsevier Masson SAS. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
188. [Predictive factors and long term carcinogenic results of patients who no longer have residual tumors (stage pT0) on specimens of total cystectomy carried out for cancer of the bladder].
- Author
-
Hitier M, Marconnet L, Luyckx F, Branchereau J, Braud G, Karam G, Bouchot O, and Rigaud J
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Neoplasm Invasiveness pathology, Neoplasm Staging, Predictive Value of Tests, Survival Rate, Survivors, Time Factors, Treatment Outcome, Urinary Bladder Neoplasms mortality, Cystectomy, Urinary Bladder Neoplasms pathology, Urinary Bladder Neoplasms surgery
- Abstract
Aim: The aim of our study was to evaluate predictive factors and long-term carcinogenic results for patients who had had a total cystectomy for cancer of the bladder and whose final histological results did not show evidence of a residual tumor., Patients and Methods: From 1988 to 2002, 192 patients had a total cystectomy for a bladder tumor. No residual tumor (pT0) was evident in the specimens of cystectomy of 22 patients (11.5%). None of the patients had distant metastasis or ganglions at the time of the initial examination., Results: Predictive factors for having no residual tumors based on the specimen of cystectomy (pT0) were an antecedent of neo-adjuvant chemotherapy (p=0.0079), an interval between the resection of the bladder and the cystectomy of more than 12 weeks (p=0.0014) and a resection of the initial bladder considered complete (p=0.0036). The average treatment of these 22 patients was 70+/-46 months. During treatment, two patients (9%) had a recurrence in the pelvis and 10 patients died including one from the development of his cancer of the bladder. Global, specific and non-recurrence survival at five years were 75%, 100% and 94%, respectively. We revealed better specific survival (p=0.0007) and without relapse (p<0.0001) in patients who no longer had a tumor on the specimen of cystectomy (pT0) compared with patients who had a residual tumor (pT+) but with no difference in global survival (p=0.0574)., Conclusion: The absence of residual tumors (pT0) on a specimen of total cystectomy for cancer of the bladder was a good factor for prognosis regarding long-term survival even if tumor development was observed. Complete resection and neo-adjuvant chemotherapy probably played a beneficial role in the future of these patients., ((c) 2009 Elsevier Masson SAS. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
189. [Results and surgical complications of living donor nephrectomy: open vs hand-assisted laparoscopic nephrectomy].
- Author
-
Branchereau J, Rigaud J, Normand G, Muller B, Lepage JY, Giral M, and Karam G
- Subjects
- Adult, Female, Humans, Kidney Transplantation, Male, Nephrectomy adverse effects, Retrospective Studies, Laparoscopy, Living Donors, Nephrectomy methods
- Abstract
Purpose: Hand-assisted laparoscopic nephrectomy in living donors is a minimally invasive surgical modality. Laparoscopic nephrectomy is now a routine procedure. This study compares an initial group of patients undergoing laparoscopic live donor nephrectomy to a group of patients undergoing open donor. Donor morbidity and graft function in the laparoscopic group were compared with those in the open group., Materials and Methods: We retrospectively reviewed the medical records of 53 consecutive laparoscopic nephrectomy and compared them with 60 consecutive open donor nephrectomies., Results: Demographic data of donors and recipients were similar in the two groups. No conversion to open surgery was necessary. Laparoscopic group patients had a shorter hospital stay compared to those undergoing open surgery. Long-term follow-up of serum creatinine levels revealed no significant differences among the two groups: at 3.6 and 12 months: 112 (+/-27) versus 122 (+/-11), 111 (+/-25) versus 119 (+/-19), 114 (+/-23) versus 122 (+/-25). There was no difference between hand-assisted laparoscopic nephrectomy (two vesico ureteral leak, three hematoma (one needed a surgical revision) and lombotomy (one vesico ureteral leak, one hematoma needed a surgical revision, two arteries stenosis). The rate of recipient ureteral stenosis in the laparoscopic and open nephrectomy groups was 0 of 39 cases and two of 60, respectively. Two vesico ureteral leak versus none appear in the lapararoscopic group., Conclusion: Hand-assisted laparoscopic nephrectomy in living donors is a safe procedure which presented low morbidity after surgery. This provides equal graft function equal urological complications compared to open live donor nephrectomy. This is our reference method.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.